Neurobiologie Psychischer Störungen 2006
DOI: 10.1007/3-540-30887-3_5
|View full text |Cite
|
Sign up to set email alerts
|

Kognitive Störungen: Koma, Delir, Demenz

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
3
0
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 396 publications
2
3
0
1
Order By: Relevance
“…Furthermore, the apolipoprotein E (apoE) genotype was determined using the LightCycler technology (Aslanidis & Schmitz, 1999). In the overall sample of n = 288 participants, for whom apoE was available at T3, allelic frequency (apoE ε2: 10.2%, apoE ε3: 72,6%, apoE ε4: 17.2%) was comparable to findings in a representative study in Germany (Förstl, 2006). For the n = 205 included in this study, allelic frequency of participants with at least one apoE ε4 was slightly higher (25% vs. 15% reported by Förstl, 2006).…”
Section: Methodssupporting
confidence: 69%
“…Furthermore, the apolipoprotein E (apoE) genotype was determined using the LightCycler technology (Aslanidis & Schmitz, 1999). In the overall sample of n = 288 participants, for whom apoE was available at T3, allelic frequency (apoE ε2: 10.2%, apoE ε3: 72,6%, apoE ε4: 17.2%) was comparable to findings in a representative study in Germany (Förstl, 2006). For the n = 205 included in this study, allelic frequency of participants with at least one apoE ε4 was slightly higher (25% vs. 15% reported by Förstl, 2006).…”
Section: Methodssupporting
confidence: 69%
“…S18). Lewy himself noted the conundrum of distinguishing between the two 26 , and it has remained a challenge throughout the past century. It cannot be excluded that some of the structures previously analyzed by EM and published as a characterization of Lewy structures were in fact CA 19 .…”
Section: Discussionmentioning
confidence: 99%
“…Yet age of onset of symptoms – not general age – is generally seen as the crucial marker predicting the course of dementia. General age is far less important because the pathology of dementia affecting cognition, psychopathology, and behavior is fundamentally different from the decline found in normal aging (Förstl, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Medications like acetylcholinesterase inhibitors and the NMDA-antagonist memantine can slow down the progression and temporarily delay cognitive decline (Förstl, 2006). In dementia, especially neuropsychiatric symptoms like depression, psychotic symptoms, anxiety, agitation, or depression frequently cause considerable suffering in patients and caregivers.…”
Section: Introductionmentioning
confidence: 99%